Clinical Nuclear Medicine

Skip Navigation LinksHome > April 2014 - Volume 39 - Issue 4 > Lymphoma as a Second Malignancy in a Patient With Neuroendoc...
Clinical Nuclear Medicine:
doi: 10.1097/RLU.0b013e31828e98c5
Interesting Images

Lymphoma as a Second Malignancy in a Patient With Neuroendocrine Tumor: Mimicking Dedifferentiation on Dual-Tracer PET/CT With 68Ga-DOTANOC and 18F-FDG

Jain, Sachin MD; Sharma, Punit MD; Dhull, Varun Singh MD; Bal, Chandrasekhar MD; Kumar, Rakesh MD, PhD

Collapse Box


Abstract: Neuroendocrine tumors (NETs) are rare tumors which express somatostatin receptors (SSTRs). We here present a case of a 50-year-old female patient with metastatic bronchial carcinoid. She underwent 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT which suggested a diagnosis of poorly differentiated NET. Biopsy of the lesion, however, revealed a second malignancy in the form of diffuse large B-cell lymphoma. Thus, very rarely, other primary tumors can mimic NETs on dual-tracer PET/CT, and biopsy is advised in doubtful cases.

© 2014 by Lippincott Williams & Wilkins


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.